Greek (ASE) Growth Pharmaceuticals & Biotech Stocks

UPDATED Feb 15, 2025

Discover Greek Pharmaceuticals & Biotech Growth Stocks that are on the ASE. Sorted by forecasted growth, these Pharmaceuticals & Biotech Stocks have higher than expected earnings or sales growth compared to other companies.

CompanyLast Price7D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv Yield
LAVI
Lavipharm
€0.843.0%-5.6%€141.0mn/aPE19.8xn/an/a
Page 1 of 1